Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : ELEV save search
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Published: 2024-04-09 (Crawled : 01:00) - elevationoncology.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -0.85%
H: 1.5%
C: 0.64%
preclinical for meeting program
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -3.87%
H: 0.0%
C: 0.0%
preclinical for meeting program
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements
Published: 2024-03-06 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 1.71%
H: 2.95%
C: -1.68%
business year financial results
Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published: 2024-03-05 (Crawled : 22:00) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 1.71%
H: 2.95%
C: -1.68%
association cancer research preclinical meeting program
Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors
Published: 2024-03-04 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 0.4%
H: 1.39%
C: -4.37%
leaders
Elevation Oncology to Participate in Upcoming Investor Conferences
Published: 2024-02-28 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -0.27%
H: 6.76%
C: 4.05%
Elevation Oncology Expands Ongoing Phase 1 Clinical Trial of EO-3021 Globally, Dosing First Patient in Japan
Published: 2024-02-22 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -1.44%
H: 5.49%
C: -1.1%
eo-3021 first japan ongoing trial
Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors
Published: 2024-01-22 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -3.16%
H: 21.22%
C: 15.1%
Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones
Published: 2024-01-05 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 11.54%
H: 43.94%
C: 32.52%
program
Elevation Oncology to Present at the Piper Sandler 35th Annual Healthcare Conference
Published: 2023-11-22 (Crawled : 12:30) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 1.64%
H: 4.49%
C: -3.51%
conference
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements
Published: 2023-11-02 (Crawled : 15:30) - elevationoncology.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 10.14%
H: 4.0%
C: -9.2%
business financial results
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 16:00) - elevationoncology.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 1.84%
H: 2.53%
C: -1.16%
conference global
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021
Published: 2023-08-16 (Crawled : 13:20) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -0.11%
H: 1.1%
C: -5.0%
eo-3021 trial
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements
Published: 2023-08-03 (Crawled : 12:20) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 0.92%
H: 0.0%
C: 0.0%
business financial results
Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer
Published: 2023-07-13 (Crawled : 13:00) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 1.32%
H: 1.31%
C: -1.96%
financial
Elevation Oncology Announces Pricing of $50 Million Public Offering
Published: 2023-06-09 (Crawled : 03:00) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -26.95%
H: 0.49%
C: -7.28%
offering
Elevation Oncology Announces Launch of Proposed Public Offering
Published: 2023-06-08 (Crawled : 20:00) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -26.95%
H: 0.49%
C: -7.28%
offering
Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements
Published: 2023-05-15 (Crawled : 13:00) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -7.41%
H: 12.0%
C: 4.86%
business financial results
Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023
Published: 2023-04-17 (Crawled : 14:20) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -2.05%
H: 4.71%
C: 1.57%
eo-3021 preclinical study
Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023
Published: 2023-03-14 (Crawled : 23:00) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -1.8%
H: 34.86%
C: 31.19%
research meeting association cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.